These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
108 related items for PubMed ID: 11261597
1. Effect of GLG-V-13, a class III antiarrhythmic agent, on potassium currents in rabbit ventricular myocytes. Virág L, Fazekas T, Iost N, Varró A, Berlin KD, Scherlag BJ, Lazzara R, Pap JG. Life Sci; 2000 Mar; 66(17):PL 253-8. PubMed ID: 11261597 [Abstract] [Full Text] [Related]
2. Electrophysiological and inotropic characterization of a novel class III antiarrhythmic agent, GLG-V-13, in the mammalian heart. Fazekas T, Carlsson L, Scherlag BJ, Mabo P, Poty H, Palmer M, Patterson E, Berlin KD, Garrison GL, Lazzara R. J Cardiovasc Pharmacol; 1996 Aug; 28(2):182-91. PubMed ID: 8856472 [Abstract] [Full Text] [Related]
3. Effect of disopyramide on potassium currents in rabbit ventricular myocytes. Virág L, Varró A, Papp JG. Naunyn Schmiedebergs Arch Pharmacol; 1998 Mar; 357(3):268-75. PubMed ID: 9550298 [Abstract] [Full Text] [Related]
4. Ionic mechanisms mediating the differential effects of methohexital and thiopental on action potential duration in guinea pig and rabbit isolated ventricular myocytes. Martynyuk AE, Morey TE, Raatikainen MJ, Seubert CN, Dennis DM. Anesthesiology; 1999 Jan; 90(1):156-64. PubMed ID: 9915324 [Abstract] [Full Text] [Related]
5. Comparison of the effect of class IA antiarrhythmic drugs on transmembrane potassium currents in rabbit ventricular myocytes. Iost N, Virág L, Varró A, Papp JG. J Cardiovasc Pharmacol Ther; 2003 Mar; 8(1):31-41. PubMed ID: 12652328 [Abstract] [Full Text] [Related]
6. Tedisamil blocks the transient and delayed rectifier K+ currents in mammalian cardiac and glial cells. Dukes ID, Cleemann L, Morad M. J Pharmacol Exp Ther; 1990 Aug; 254(2):560-9. PubMed ID: 2384886 [Abstract] [Full Text] [Related]
7. Effects of sematilide, a novel class III antiarrhythmic agent, on membrane currents in rabbit atrial myocytes. Ishii Y, Muraki K, Kurihara A, Imaizumi Y, Watanabe M. Eur J Pharmacol; 1997 Jul 23; 331(2-3):295-302. PubMed ID: 9274992 [Abstract] [Full Text] [Related]
8. Terikalant, an inward-rectifier potassium channel blocker, does not abolish the cardioprotection induced by ischemic preconditioning in the rat. Schultz JE, Kwok WM, Hsu AK, Gross GJ. J Mol Cell Cardiol; 1998 Sep 23; 30(9):1817-25. PubMed ID: 9769237 [Abstract] [Full Text] [Related]
9. Effect of the antifibrillatory compound tedisamil (KC-8857) on transmembrane currents in mammalian ventricular myocytes. Jost N, Virág L, Hála O, Varró A, Thormählen D, Papp JG. Curr Med Chem; 2004 Dec 23; 11(24):3219-28. PubMed ID: 15579009 [Abstract] [Full Text] [Related]
10. Effects of MS-551, a new class III antiarrhythmic drug, on action potential and membrane currents in rabbit ventricular myocytes. Nakaya H, Tohse N, Takeda Y, Kanno M. Br J Pharmacol; 1993 May 23; 109(1):157-63. PubMed ID: 7684298 [Abstract] [Full Text] [Related]
17. Effects of ambasilide, quinidine, flecainide and verapamil on ultra-rapid delayed rectifier potassium currents in canine atrial myocytes. Yue L, Feng JL, Wang Z, Nattel S. Cardiovasc Res; 2000 Apr 01; 46(1):151-61. PubMed ID: 10727663 [Abstract] [Full Text] [Related]
18. [Ionic mechanisms of cardiotropic action of a new class III antiarrhythmic drug RG-2]. Reznik AV, Fedorov VV, Kokoz IuM, Korystova AF, Rozenshtraukh LV, Golitsyn SP, Ruda MIa, Chazov EI. Kardiologiia; 2003 Apr 01; 43(10):76-81. PubMed ID: 14593359 [Abstract] [Full Text] [Related]
19. Mechanisms of action of antiarrhythmic agent bertosamil on hKv1.5 channels and outward potassium current in human atrial myocytes. Godreau D, Vranckx R, Hatem SN. J Pharmacol Exp Ther; 2002 Feb 01; 300(2):612-20. PubMed ID: 11805224 [Abstract] [Full Text] [Related]